IDH1 and glioblastoma: In a rat bearing GBM tumors with different IDH1 status, injection of hyperpolarized [1-13C] α-ketoglutarate led to hyperpolarized [1-13C] glutamate production, with these levels significantly lower in mutant IDH1 tumors compared with their IDH1-wild type counterparts [190].